Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep ; volume:20 ; number:1 ; day:3 ; month:10 ; year:2023 ; pages:1-12 ; date:12.2023
Virology journal ; 20, Heft 1 (3.10.2023), 1-12, 12.2023
- Creator
-
Matsiela, Matome Selina
Naicker, Leeann
Khoza, Thandeka
Mokoena, Nobalanda
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-023-02180-2
- URN
-
urn:nbn:de:101:1-2024013114174898749630
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Matsiela, Matome Selina
- Naicker, Leeann
- Khoza, Thandeka
- Mokoena, Nobalanda
- SpringerLink (Online service)
Other Objects (12)
Recognizing rift valley fever
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens
Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3
Genome characterization of Rift Valley fever virus isolated from cattle, goats and sheep during interepidemic periods in Kenya
Rift Valley fever and Brucella spp. in ruminants, Somalia
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
Observations on rift valley fever virus and vaccines in Egypt
Rift valley fever outbreak in Sembabule District, Uganda, December 2020
Universal primers for rift valley fever virus whole-genome sequencing
Recognizing rift valley fever
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens
Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3
Genome characterization of Rift Valley fever virus isolated from cattle, goats and sheep during interepidemic periods in Kenya
Rift Valley fever and Brucella spp. in ruminants, Somalia
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
Observations on rift valley fever virus and vaccines in Egypt
Rift valley fever outbreak in Sembabule District, Uganda, December 2020
Universal primers for rift valley fever virus whole-genome sequencing
Recognizing rift valley fever
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
Comparison of enzyme-linked immunosorbent assay systems using rift valley fever virus nucleocapsid protein and inactivated virus as antigens
Evaluation of the immunogenicity and protective efficacy of an inactivated vaccine candidate for sheep infected with ovine parainfluenza virus type 3
Genome characterization of Rift Valley fever virus isolated from cattle, goats and sheep during interepidemic periods in Kenya
Rift Valley fever and Brucella spp. in ruminants, Somalia
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine
Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases
Observations on rift valley fever virus and vaccines in Egypt
Rift valley fever outbreak in Sembabule District, Uganda, December 2020